Serum Iron Protects from Renal Postischemic Injury.

Journal of the American Society of Nephrology : JASN

4 years ago

Serum Iron Protects from Renal Postischemic Injury.

Ben Mkaddem S, Beaumont C, Grapton D, Flamant M, Daugas E, Mesnard L, Benhamou M, Amano MT, Mathieu JRR, Monteiro RC, Peyssonnaux C, Fricot A, Vaugier C, Camara NOS, Chemouny JM, Ginzburg YZ, Matignon M, Dussiot M, Hermine O, Vrtovsnik F, Peraldi MN, Berrou C, Wang PHM, Maciel TT, Moura IC

Renal transplants remain a medical challenge, because the parameters governing allograft outcome are incompletely identified. Here, we investigated the role of serum iron in the sterile inflammation that follows kidney ischemia-reperfusion injury. In a retrospective cohort study of renal allograft recipients (n=169), increased baseline levels of serum ferritin reliably predicted a positive outcome for allografts, particularly in elderly patients. In mice, systemic iron overload protected against renal ischemia-reperfusion injury-associated sterile inflammation. Furthermore, chronic iron injection in mice prevented macrophage recruitment after inflammatory stimuli. Macrophages cultured in high-iron conditions had reduced responses to Toll-like receptor-2, -3, and -4 agonists, which associated with decreased reactive oxygen species production, increased nuclear localization of the NRF2 transcription factor, increased expression of the NRF2-related antioxidant response genes, and limited NF-κB and proinflammatory signaling. In macrophage-depleted animals, the infusion of macrophages cultured in high-iron conditions did not reconstitute AKI after ischemia-reperfusion, whereas macrophages cultured in physiologic iron conditions did. These findings identify serum iron as a critical protective factor in renal allograft outcome. Increasing serum iron levels in patients may thus improve prognosis of renal transplants.

Publisher URL: https://www.ncbi.nlm.nih.gov/pubmed/28784700

DOI: PubMed:28784700